Skip Nav Destination
Issues
1 June 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
The Biology Behind
Reviews
Human Cancer Biology
Imaging, Diagnosis, Prognosis
Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer
Catherine A. Foss; Ronnie C. Mease; Hong Fan; Yuchuan Wang; Hayden T. Ravert; Robert F. Dannals; Rafal T. Olszewski; Warren D. Heston; Alan P. Kozikowski; Martin G. Pomper
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy
Patrick J. Bastian; Ganesh S. Palapattu; Xiaohui Lin; Srinivasan Yegnasubramanian; Leslie A. Mangold; Bruce Trock; Mario A. Eisenberger; Alan W. Partin; William G. Nelson
Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas
Christian Mawrin; Tina Sasse; Elmar Kirches; Siegfried Kropf; Thomas Schneider; Christoph Grimm; Claudia Pambor; Christian K. Vorwerk; Raimund Firsching; Uwe Lendeckel; Knut Dietzmann
Increased Cyclooxygenase-2 Expression in Duodenal Compared with Colonic Tissues in Familial Adenomatous Polyposis and Relationship to the −765G → C COX-2 Polymorphism
Lodewijk A.A. Brosens; Christine A. Iacobuzio-Donahue; Josbert J. Keller; Steven R. Hustinx; Ralph Carvalho; Folkert H. Morsink; Linda M. Hylind; G. Johan Offerhaus; Francis M. Giardiello; Michael Goggins
Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer
Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G. Johnston; Rodolfo Montironi; David J.J. Waugh
Cancer Therapy: Clinical
Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)
Alex Sparreboom; Charity D. Scripture; Vuong Trieu; Paul J. Williams; Tapas De; Andrew Yang; Bridget Beals; William D. Figg; Michael Hawkins; Neil Desai
A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors
Maurice A. Wright; Geraldine Morrison; Pengxin Lin; Gregory D. Leonard; Dat Nguyen; Xaiodu Guo; Eva Szabo; Jon L. Hopkins; Jorge P. Leguizamo; Nancy Harold; Suzanne Fioravanti; Barbara Schuler; Brian P. Monahan; M. Wasif Saif; Mary G. Quinn; Janet Pang; Jean L. Grem
Treatment of Relapsed Chronic Lymphocytic Leukemia by 72-Hour Continuous Infusion or 1-Hour Bolus Infusion of Flavopiridol: Results from Cancer and Leukemia Group B Study 19805
John C. Byrd; Bercedis L. Peterson; Janice Gabrilove; Olatoyosi M. Odenike; Michael R. Grever; Kanti Rai; Richard A. Larson; the Cancer and Leukemia Group B
Cancer Therapy: Preclinical
Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation
Cristina R. Antonescu; Peter Besmer; Tianhua Guo; Knarik Arkun; Glory Hom; Beata Koryotowski; Margaret A. Leversha; Philip D. Jeffrey; Diann Desantis; Samuel Singer; Murray F. Brennan; Robert G. Maki; Ronald P. DeMatteo
Increased Renal Calcium Reabsorption by Parathyroid Hormone–Related Protein Is a Causative Factor in the Development of Humoral Hypercalcemia of Malignancy Refractory to Osteoclastic Bone Resorption Inhibitors
Etsuro Onuma; Yumiko Azuma; Hidemi Saito; Toshiaki Tsunenari; Toshihiko Watanabe; Manabu Hirabayashi; Koh Sato; Hisafumi Yamada-Okabe; Etsuro Ogata
Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors
Gang Li; Ling Tian; Jian-mei Hou; Zhen-yu Ding; Qiu-ming He; Ping Feng; Yan-jun Wen; Fei Xiao; Bing Yao; Ru Zhang; Feng Peng; Yu Jiang; Feng Luo; Xia Zhao; Lin Zhang; Qiao Zhou; Yu-quan Wei
High Thymidylate Synthase Expression in Colorectal Cancer with Microsatellite Instability: Implications for Chemotherapeutic Strategies
Luigi Ricciardiello; Claudio Ceccarelli; Graziella Angiolini; Milena Pariali; Pasquale Chieco; Paola Paterini; Guido Biasco; Giuseppe N. Martinelli; Enrico Roda; Franco Bazzoli
Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu In vivo Model of Human Multiple Myeloma
Pierfrancesco Tassone; Paola Neri; Renate Burger; Rocco Savino; Masood Shammas; Laurence Catley; Klaus Podar; Dharminder Chauhan; Serena Masciari; Antonella Gozzini; Pierosandro Tagliaferri; Salvatore Venuta; Nikhil C. Munshi; Kenneth C. Anderson
Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells
Alessio Nencioni; Lucia Wille; Giovanna Dal Bello; Davide Boy; Gabriella Cirmena; Sebastian Wesselborg; Claus Belka; Peter Brossart; Franco Patrone; Alberto Ballestrero
Cancer Prevention
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.